CrossrefInfokarte
Resistance to covalent Bruton's tyrosine kinase inhibitors in diffuse large B‑cell lymphoma: Molecular mechanisms and therapeutic implications (Review)
International Journal of Oncology · 2026-10-09 · 69 (5) · 1-23
DOI: 10.3892/ijo.2026.5947 ↗Abstract
Kein Abstract verfügbar.
EUVIMED